<DOC>
	<DOC>NCT01784718</DOC>
	<brief_summary>This is a single patient compassionate use protocol to determine whether Buphenyl (4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.</brief_summary>
	<brief_title>Buphenyl Therapy for Byler's Disease</brief_title>
	<detailed_description />
	<mesh_term>Cholestasis, Intrahepatic</mesh_term>
	<mesh_term>4-phenylbutyric acid</mesh_term>
	<criteria>Byler Disease Cholestasis unresponsive to pharmacologic therapy Allergy/Hypersensitivity to Buphenyl</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>